Browse Related Topics For:

Biotechnology

282
Patents
254
Pharmaceutical Industry
135
Patent Litigation
105
FDA
103
Life Sciences
99
Patent Infringement
81
Patent-Eligible Subject Matter
76
Pharmaceutical Patents
58
DNA
58
Medical Devices
57
EPA
56
USPTO
55
SCOTUS
53
USDA
52
Popular
42
EU
40
Myriad
38
Prescription Drugs
35
AMP v Myriad
33
Healthcare
32
ANDA
30
Human Genes
29
Chemicals
27
Biosimilars
25
Biofuel
25
Mayo v. Prometheus
25
OSTP
23
Department of Energy (DOE)
23
Patent Trial and Appeal Board
22
Toxic Substances Control Act (TSCA)
21
Genetic Materials
21
Innovation
21
Inter Partes Review (IPR) Proceeding
21
Nanotechnology
21
Patent Applications
21
Public Comment
20
Biobased Chemicals
20
Bioproducts
20
China
20
Renewable Energy
20
Venture Capital
19
Generic Drugs
18
Biologics
18
Myriad-Mayo
18
Technology
17
Infringement
16
America Invents Act
16
Regulatory Standards
15
CLS Bank v Alice Corp
15
Intellectual Property Protection
15
Patent Reform
15
Public Meetings
15
Startups
14
FIFRA
14
GMO
14
Medical Research
14
Novartis
14
UK
13
Patent Invalidity
13
Pfizer
13
Section 101
12
European Medicines Agency (EMA)
12
Manufacturers
12
Regulatory Oversight
12
Research and Development
11
Australia
11
Cancer
11
Energy Sector
11
Initial Public Offerings
11
Pesticides
11
Sequenom
10
Actavis Inc.
10
BRCA
10
Clinical Trials
10
Compliance
10
FDA Approval
10
Genetically Engineered Seed
10
Monsanto
9
Clean Water Act
9
Emerging Growth Companies
9
Entrepreneurs
9
Farms
9
Food Labeling
9
Food Manufacturers
9
Foreign Investment
9
Funding
9
GlaxoSmithKline
9
Mylan Pharmaceuticals
9
Obviousness
9
Private Equity
9
Software
8
Acquisitions
8
CERCLA
8
Clean Air Act
8
Copyright
8
Diagnostic Method
8
European Commission
8
European Patent Office
8
Investors
8
Merck
8
Mergers
8
Obama Administration
8
Personalized Medicine
8
Product of Nature Doctrine
8
RCRA
8
Stem cells
8
Tax Credits
8
Transparency
8
UK Brexit
7
Appeals
7
Bowman v Monsanto
7
BPCIA
7
Claim Construction
7
Diagnostic Tests
7
Genetic Testing
7
Inventions
7
Medicare
7
OMB
7
Patent Prosecution
7
Proposed Legislation
7
Scientific Research
7
Teva Pharmaceuticals
7
Trans-Pacific Partnership
6
3D Printing
6
AbbVie
6
Affordable Care Act
6
AstraZeneca
6
Declaratory Judgments
6
Drug Pricing
6
Economic Development
6
Emerging Technology Companies
6
En Banc Review
6
Enforcement Actions
6
First-to-File
6
First-to-Invent
6
FSMA
6
Janssen Pharmaceuticals
6
National Academy of Sciences (NAS)
6
Oil & Gas
6
Patent Exhaustion
6
Prior Art
6
Regulatory Agenda
6
SEC
6
Summary Judgment
6
Trade Secrets
6
Trump Administration
6
Universities
5
21st Century Cures Initiative
5
Amgen
5
Animal Testing
5
Apotex
5
Capital Raising
5
CMS
5
Comment Period
5
Covered Business Method Patents
5
Department of Defense (DOD)
5
European Court of Justice (ECJ)
5
European Patent Convention
5
Food Safety
5
FTC
5
Hedge Funds
5
Inventors
5
JOBS Act
5
Licenses
5
OECD
5
Petition for Writ of Certiorari
5
Preemption
5
Request For Information
5
Venture Funding
4
23andMe
4
Abbott Laboratories
4
Amicus Briefs
4
APHIS
4
Ariosa
4
Barack Obama
4
Biologics Price Competition and Innovation Act of 2009
4
Biomass
4
Biopharmaceutical
4
Climate Change
4
Corporate Taxes
4
Digital Health
4
Due Diligence
4
Eli Lilly
4
Expert Testimony
4
Exports
4
FDCA
4
Financing
4
Food Supply
4
Gene Patenting
4
Guidance Update
4
Health Care Providers
4
HHS
4
Hospitals
4
India
4
IP License
4
IPO
4
Legal Perspectives
4
Legislative Agendas
4
Limelight v Akamai
4
Member State
4
Natural Products
4
Par Pharmaceutical
4
Pending Legislation
4
Post-Grant Review
4
Professional Conferences
4
Renewable Fuel Standard
4
Safe Harbors
4
Sandoz
4
Securities Fraud
4
Seeds
4
Sunshine Act
4
Tax Incentives
4
Telemedicine
4
Trade Agreements
4
Unified Patent Court
4
Unitary Patent
4
Valuation
3
21st Century Cures Act
3
Ambry
3
Anti-Corruption
3
Antimicrobials
3
Bayh-Dole Act
3
Bribery
3
Cephalon
3
Class Action
3
Clinical Laboratories
3
Confidential Information
3
Corporate Counsel
3
Cuba
3
Cybersecurity
3
Defend Trade Secrets Act (DTSA)
3
Direct Infringement
3
Disclosure Requirements
3
Discovery
3
Dismissals
3
Draft Guidance
3
E-Commerce
3
Enforcement
3
Equity Financing
3
European Food Safety Authority (EFSA)
3
Exemptions
3
False Claims Act (FCA)
3
FCC
3
Final Rules
3
Financial Institutions
3
Genentech
3
Germany
3
Hatch-Waxman
3
Health Information Technologies
3
Health Insurance
3
Healthcare Reform
3
Imports
3
Injunctions
3
Innovation Act
3
Insurance Industry
3
Intellectual Property Litigation
3
Inversion
3
Japan
3
Method Claims
3
Misappropriation
3
Monopolization
3
Motion to Dismiss
3
Netherlands
3
New Legislation
3
NIH
3
Noninfringement
3
Office of Chemical Safety & Pollution Prevention (OCSPP)
3
Orphan Drugs
3
PATENT Act
3
Patent Royalties
3
Patent Term Adjustment
3
Patent Trolls
3
PHRMA
3
Publicly-Traded Companies
3
Referendums
3
Regenerative Medicine
3
Risk Management
3
Royalties
3
Sandoz v Amgen
3
Sanofi-Aventis
3
Software Patents
3
Sustainability
3
Telecommunications
3
Trade Associations
3
Trade Policy
3
Trademarks
3
Utility Patents
3
Webinars
3
White Collar Crimes
3
Young Lawyers
2
Abstract Ideas
2
Abuse of Process
2
ACLU
2
Additive Manufacturing
2
Advisory Committee
2
Agricultural Land
2
Aircraft
2
Akamai Technologies
2
Alice Corporation
2
All Natural
2
Allergan Inc
2
Alzheimer's
2
Antitrust Litigation
2
Banks
2
Big Data
2
Brazil
2
Bristol-Myers Squibb
2
Business Taxes
2
Buyouts
2
Canada
2
Capital Formation
2
Celltrion
2
Cloud Computing
2
Complete Genomics
2
Corporate Officers
2
Country of Origin
2
Criminal Prosecution
2
Cross-Border Transactions
2
Crowdfunding
2
Customs
2
Data Protection
2
Diesel Fuel
2
Dispute Resolution
2
Dow Jones
2
Early Stage Companies
2
Energy Policy
2
Environmental Liability
2
Environmental Policies
2
Ethics
2
EU-US Privacy Shield
2
Farm Workers
2
Fast Track Process
2
FCPA
2
Federal Acquisition Regulations (FAR)
2
Federal Funding
2
Federal Register
2
FFDCA
2
Forest Laboratories
2
France
2
Free Speech
2
General Motors
2
General Services Administration (GSA)
2
Generic
2
Genetic Technologies Ltd.
2
Genetically Engineered Animals
2
Gilead Sciences
2
Good Faith
2
Grants
2
Green Chemistry
2
H-1B
2
Hazardous Waste
2
HIPAA
2
Hospira
2
Indefiniteness
2
Induced Infringement
2
Information Reports
2
Integra
2
Inter Partes Reexamination
2
Interference Proceeding
2
International Data Transfers
2
Investment
2
IRB
2
IRIS
2
Italy
2
Joinder
2
Joint Venture
2
Jurisdiction
2
Kickstarter
2
Lyft
2
Marketing
2
Means-Plus-Function
2
Medicaid
2
Menu-Labeling
2
Mexico
2
Misrepresentation
2
Motion to Amend
2
NAFTA
2
Nanomaterials
2
NASA
2
Nasdaq
2
National Cancer Moonshot
2
Nautilus Inc. v. Biosig Instruments
2
New Guidance
2
OFPP
2
OIG
2
On-Sale Bar
2
Organic
2
Patent Examinations
2
Patent Ownership
2
Patent Term Extensions
2
Patent Validity
2
Patient Access
2
Personal Liability
2
Petition For Rehearing
2
Physicians
2
Plant Patents
2
Pleading Standards
2
Pleadings
2
Policies and Procedures
2
Pollinators
2
Precision Medicine Initiative (PMI)
2
Premarket Approval Applications
2
Product Exclusivity
2
Prometheus
2
Public Health
2
Regulatory Agencies
2
Reimbursements
2
Research Funding
2
Reversal
2
Risk Assessment
2
Sanctions
2
Settlement
2
Shareholder Activism
2
Small Business
2
SNUR
2
Social Media
2
Software Developers
2
South Africa
2
Spain
2
Substance Abuse
2
Supplementary Protection Certificate
2
Surveys
2
Switzerland
2
Takeda Pharmaceuticals
2
Tax Rates
2
Technical Conference
2
Technology Sector
2
The Common Rule
2
The Enlarged Board of Appeals
2
The Patent Act
2
The Patent Box
2
Toxic Chemicals
2
Trade Promotion Authority
2
U.S. Commerce Department
2
US-EU Safe Harbor Framework
2
Valeant
2
Waters of the United States
2
Watson Pharmaceuticals
2
Working Groups
2
WTO
1
aBLA
1
Accelerated Examination Program
1
Accredited Investors
1
Acquisition Agreements
1
Administrative Procedure Act
1
Advanced Notice of Proposed Rulemaking (ANPRM)
1
Advertising
1
Africa
1
Agribusiness
1
AIDS
1
Amended Regulation
1
American Arbitration Association
1
Angel Investors
1
Animal Food
1
Animal Patents
1
Anti-Kickback Statute
1
Anti-Monopoly
1
Anticipation
1
Anticompetitive Behavior
1
Antitrust Provisions
1
Apple
1
Appraisal Awards
1
Appropriation
1
Arbitration
1
Artificial Intelligence
1
Asset Protection
1
Asset Seizure
1
Assignment of Inventions
1
Assignments
1
Assisted Living Facility
1
ASTM
1
Australian Competition and Consumer Commission
1
Australian Patent Office
1
Automotive Industry
1
Bad Faith
1
Ballot Measures
1
Ballots
1
Banking Sector
1
Bayer
1
BEPS
1
Best Efforts Clauses
1
Best Practices
1
BIA
1
Bilski
1
Biodegradable
1
Bioengineering
1
Biomass Energy Research
1
Bipartisan Agreement
1
BIS
1
Board of Directors
1
Boeing
1
BRACA Genes
1
Broadest Reasonable Interpretation Standard
1
Budget Cuts
1
Buying a Business
1
CAD/CAM Software
1
CAFC
1
Capital Gains
1
Capital Markets
1
Carbon Emissions
1
Certiorari
1
CFDA
1
CFIUS
1
CGMP
1
Chamber of Commerce
1
Chemical Compounds
1
Chemical Weapons
1
Chevron Deference
1
Chief Compliance Officers
1
Chilling Effect
1
Chrysler
1
Cisco
1
City of San Jose
1
Clean Tech
1
Clear Error Standard
1
Climate Action Plan
1
Co-payments
1
Coca Cola
1
Collaboration
1
Colleges
1
Commercial Bankruptcy
1
Commercial Marketing
1
Commercial Speech
1
Commercially Reasonable Efforts
1
Competition
1
Competitive Bidding
1
Complex Litigation
1
Compulsory Licenses
1
Computer Fraud and Abuse Act (CFAA)
1
Confidential Business Information (CBI)
1
Construction Disputes
1
Contamination
1
Continuing Legal Education
1
Contract Disputes
1
Copyright Infringement
1
Copyright Office
1
Corporate Integrity Agreement
1
Corporate Misconduct
1
Corruption
1
Counterclaims
1
Covered Business Method Proceedings
1
Covered Entities
1
Credit Suisse
1
CRISPR
1
Crops
1
Cuozzo Speed Technologies
1
Cyber Attacks
1
Cybersecurity Information Sharing Act (CISA)
1
D&O Insurance
1
Damages
1
Data Breach Plans
1
Data Collection
1
Data Security
1
Data Use Policies
1
Databases
1
Daubert Standards
1
De Novo Standard of Review
1
De-Risking
1
Department of Agriculture
1
Department of Transportation (DOT)
1
Deregulation
1
Derivative Suit
1
Design Patent
1
Deutsche Bank
1
Dietary Supplements
1
Directors
1
Disgorgement
1
Divestment
1
Divided Infringement
1
Doctrine of Equivalents
1
DOJ
1
DOL
1
Donations
1
Double Patent
1
Drug Approvals
1
Drug Design
1
DuPont
1
Economic Espionage Act
1
Educational Institutions
1
EEA
1
Election Results
1
Electricity
1
Electronic Filing
1
Electronic Medical Records
1
Electronic Protected Health Information (ePHI)
1
Electronic Reporting
1
Email
1
Emergency Response
1
Employee Training
1
Endangered Species Act (ESA)
1
Enterprise Zones
1
Entertainment Industry
1
Environmental Violations
1
EPO
1
Estoppel
1
Ethanol
1
Events
1
Evidence
1
Ex Parte
1
Ex Partes Reexamination
1
Examiners
1
Exclusionary Clauses
1
Exclusive Licenses
1
Executive Orders
1
Exit Strategies
1
Expedited FDA Approval
1
Export Administration Regulations
1
Export Controls
1
False Advertising
1
False Statements
1
Fantasy Sports
1
FDARA
1
FDASIA
1
FDIC
1
Federal Budget
1
Federal Pilot Programs
1
Federal Procurement Systems
1
Federal Rule 12(b)(6)
1
Federal Rules of Civil Procedure
1
Federal Sentencing Guidelines
1
Fee-Shifting
1
Fees
1
Fiduciary Rule
1
Final Guidance
1
Financial Conduct Authority (FCA)
1
Financial Crisis
1
Financial Instruments
1
Financial Markets
1
FinTech
1
First Amendment
1
Fixing America’s Surface Transportation Act (FAST Act)
1
Flame Retardant
1
Ford Motor
1
Foreign Acquisitions
1
Foreign Nationals
1
Foreign Patent Applications
1
Foreign Workers
1
FRAND
1
Fraud
1
Fresenius
1
Frozen Assets
1
FTC v Actavis
1
Functionality
1
GAAP
1
GATT
1
GDP
1
General Data Protection Regulation (GDPR)
1
Genome Project
1
Genzyme
1
Getty Images
1
Global Economy
1
Global Market
1
Global Standards
1
GM/Synbio Algae Project
1
GMO Bans
1
Goldman Sachs
1
Green Guides
1
Greenhouse Gas Emissions
1
Grocery Stores
1
Guilty Pleas
1
Hackers
1
Hart-Scott-Rodino Act
1
Harvard University
1
Hazardous Substances
1
Heads of Agreement (HOA)
1
Health Insurance Exchanges
1
Healthcare Costs
1
Hiring Freeze
1
Hitachi
1
HITECH
1
Honeybees
1
Human Rights
1
Hydrocarbons
1
Incentives
1
Incident Response Plans
1
Income Taxes
1
Indictments
1
Industrial Design
1
Industry Consolidation
1
Information Disclosure Statement
1
Informed Consent
1
Inherent Disclosure Doctrine
1
Insider Trading
1
Intangible Property
1
Intellectual Property Owners Association
1
InterDigital Communications v ITC
1
Interest Rates
1
International Litigation
1
Internet of Things
1
Investment Banks
1
Investment Funds
1
IP Assignment Agreements
1
Ireland
1
IRS
1
ITAR
1
ITC
1
Janssen v Celltrion
1
Jazz Pharmaceuticals
1
Johnson & Johnson
1
Joint Infringement
1
JPMorgan Chase
1
Judicial Review
1
Kappos
1
Kickbacks
1
L-1 Visas
1
Labeling
1
Laboratories
1
Landlords
1
Lautenberg Act
1
Leases
1
LEED Certified
1
LEED Rules
1
Leveraged Lending
1
Liability Insurance
1
License Agreements
1
License Fees
1
Life Technologies Corp v Promega Corp
1
Limelight
1
Limelight Networks
1
Litigation Strategies
1
Local Ordinance
1
Local Sourcing
1
London Stock Exchange
1
Lost Profits
1
Luxembourg
1
Machine-or-Transformation Test
1
Manufacturing Facilities
1
Marijuana
1
Martin Shkreli
1
Material Adverse Effects
1
Mayor di Blasio
1
Meal and Entertainment Expenditures
1
Media
1
Medical Reimbursement
1
Medicare Part B
1
Medtronic
1
Medtronic v Boston Scientific
1
Memorandum of Guidance
1
Mental Health
1
Methane
1
mHealth
1
Microsoft
1
Milestone Payments
1
Mining
1
Misleading Impressions
1
Misleading Statements
1
Mobile Apps
1
Mobile Devices
1
MOFCOM
1
Mortgages
1
Motion for Sanctions
1
Motion To Stay
1
MPEP
1
Multi-Factor Test
1
Municipal Bonds
1
Municipalities
1
Myriad v Ambry
1
NAICS
1
Name and Likeness
1
Nanomedicine
1
Natural Resources
1
NCAA
1
NEPA
1
NIST
1
Noerr-Pennington Doctrine
1
Non-Compete Agreements
1
Non-Disclosure Agreement
1
Non-Practicing Entities
1
Notice of Intent
1
NPRM
1
NRDC
1
Nunc Pro Tunc
1
O-1 Aliens of Extraordinary Ability
1
OEHHA
1
OFAC
1
Off-Campus Departments
1
Off-Label Use
1
Offshore Companies
1
Olympics
1
Omissions
1
ONC
1
Online Drug Sales
1
Open Payments
1
Opioid
1
Opt-Outs
1
Orange Book
1
Order to Stay
1
Organic Seed Growers & Trade Assn
1
OSHA
1
OTC
1
Outpatient Prospective Payment System (OPPS)
1
Partnerships
1
Patent Cooperation Treaty
1
Patent Dance
1
Patent Expiration
1
Patent Owner Preliminary Response
1
Patent Portfolios
1
Patent Prosecution Highway
1
Patent-in-Suit
1
Patents 4 Patients
1
Patents for Humanity
1
Patient-Specific
1
Pay-For-Delay
1
PCBs
1
PDUFA
1
Pediatrics
1
Penalties
1
Performance and Accountability Report
1
Permanent Injunctions
1
Personal Care Products
1
Petitions for Review
1
Pharmacies
1
PHSA
1
Poison Pill
1
Poland
1
Political Appointments
1
Political Campaigns
1
Portal
1
Posting Requirements
1
Power Plants
1
Premiums
1
PricewaterhouseCoopers
1
Pricing Requirements
1
Prior User
1
Prioritized Examination
1
Priority Patent Claims
1
Private Equity Funds
1
Private Right of Action
1
Proctor & Gamble
1
Product Defects
1
Product Development Protocols
1
Product Hopping
1
Product Labels
1
Product Packaging
1
Proposed Amendments
1
Provider Payments
1
Provisional Applications
1
Public Disclosure
1
Public Domain
1
Public Funds
1
Public Nuisance
1
Public Policy
1
Public Private Partnerships (P3s)
1
Public Utilities Commission
1
Punitive Damages
1
Qualifying Income
1
R&D
1
RanBaxy
1
Ratification
1
Real Party in Interest
1
Recordkeeping Requirements
1
Recycling
1
Registration
1
Registration Requirement
1
Regulatory Reform
1
Reimbursement Codes
1
REIT
1
Remand
1
Remediation
1
Renewable Fuel
1
Repeal
1
Reporting Requirements
1
Request for Continued Examination
1
Research Tools
1
Retailers
1
Revenue
1
Reverse Takeovers
1
Right of Publicity
1
Risk-Based Approaches
1
RMBS
1
ROI
1
Roslin
1
Royal Bank of Scotland
1
Rule 10b-5
1
Rulemaking Process
1
Russia
1
S&P
1
Safe Drinking Water Act
1
SAIC
1
Salmon
1
SALT
1
Sarbanes-Oxley
1
Satire
1
SBA
1
SBIRs
1
Scope of the Claim
1
Scotland
1
Secretary of HHS
1
Section 10(b)
1
Section 102
1
Section 11
1
Section 271
1
Section 5
1
Securities
1
Securities Act
1
Securities Litigation
1
Securities Violations
1
Series A
1
Set-Asides
1
Shareholders
1
Sharing Economy
1
Silicon Valley
1
SIPO
1
Site-Neutral Exception
1
SMEs
1
SnapChat
1
Solar Energy
1
Source Code
1
SpaceX
1
Special Districts
1
Special Purpose Vehicles
1
Standing
1
State Regulators
1
State-Owned Enterprises
1
Stock Exchange
1
Stock Prices
1
Stocks
1
Storm Water Pollution Prevention Plan
1
Stormwater Discharge Permits
1
Strategic Planning
1
Strict Liability
1
STRONG Patents Act
1
STTR
1
Student Athletes
1
Students
1
Subject Matter Conflicts
1
Subject Matter Jurisdiction
1
Subprime Mortgages
1
Subsidiaries
1
Supply Chain
1
Surgery
1
Takeover Bids
1
Tariffs
1
Teaching Hospitals
1
Tech Industry
1
Technical Standards
1
Tenants
1
Testimony
1
Textiles
1
The Copyright Act
1
The Nagoya Protocol
1
Third-Party
1
Tobacco Regulations
1
Tort
1
Tourists
1
Toxic Exposure
1
Trade Relations
1
Trade Restrictions
1
Trade Secrets Protection Act of 2014
1
Trade Unions
1
Trademark Application
1
Trademark Infringement
1
Trademark Registration
1
Trademark Trial and Appeal Board
1
Training
1
Transfer Pricing
1
Transfer Taxes
1
Transfers
1
Transformative Use
1
Transportation Industry
1
Travel Expenses
1
TRIPS Agreement
1
Twombly/Iqbal Pleading Standard
1
Uber
1
UK Competition and Markets Authority (CMA)
1
UK Supreme Court
1
Unfair or Deceptive Trade Practices
1
Uniform Trade Secrets Acts
1
University of California
1
Urban Planning & Development
1
US Trade Policies
1
User Fees
1
USTR
1
Vacated
1
Video Games
1
Visas
1
Volatile Organic Compounds (VOC)
1
Waivers
1
WARF
1
Washington Mutual
1
Waste
1
Water
1
Water Pollution
1
Wind Power
1
WIPO
1
Work Computer
1
Worker Protection Standard
1
Workplace Hazards
1
Works Council
1
Written Descriptions
1
Wyeth
1
Yates Memorandum